Movie star Angelina Jolie tested positive for a "faulty gene" at the center of a high-profile legal battle in the United States that challenges whether human genes can belong to a corporation.
The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.
Rival legal teams, well-financed and highly motivated, are preparing for court battles over the coming months on laws enacted in Arkansas and North Dakota that would impose the toughest bans on abortion in ...
Sweden will no longer require sex change patients to be sterilised after a law banning the practice entered into force on Thursday.
(AP)—A state judge has suspended a Georgia law banning abortions for women who are more than 20 weeks pregnant.
(AP) -- The Supreme Court on Monday threw out a lower court ruling allowing human genes to be patented, a topic of enormous interest to cancer researchers, patients and drug makers.
Amid anticipation akin to a major sports event, the US Supreme Court begins hearing arguments Monday on President Barack Obama's landmark health reform, a case with huge implications for the nation and 2012 elections.
AMP presented testimony to the Patent and Trademark Office requesting moratorium on human gene patenting
Today, the Association for Molecular Pathology (AMP) asked the U.S. Patent and Trademark Office (USPTO) to place a moratorium on the issuing of patents on human genes during testimony presented at an Agency hearing on genetic ...
The American Civil Liberties Union and the Public Patent Foundation have petitioned the U.S. Supreme Court to hear Association for Molecular Pathology v. U.S. Patent and Trademark Office, a case that challenges the validity ...
(AP) -- Confined to a wheelchair, in constant pain and unable to bathe without help, a 63-year-old grandmother has forced the issue of assisted suicide into Canadian courts for the third time in two decades.
A federal appeals court on Friday ruled in favor of Myriad Genetics after a legal battle over whether the US company could keep its patent on genes linked to an inherited form of breast cancer.